HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$3.98
Day range
$3.82 - $4.10
Year range
$3.11 - $20.72
Market cap
117.25M USD
Avg Volume
61.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.01M | 529.48% |
Net income | -5.99M | -250.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 834.64K | 33,939.07% |
Total assets | 1.04M | -80.41% |
Total liabilities | 599.91K | -80.90% |
Total equity | 442.07K | — |
Shares outstanding | 29.61M | — |
Price to book | 398.00 | — |
Return on assets | -955.27% | — |
Return on capital | -1,338.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.99M | -250.06% |
Cash from operations | -1.00M | 49.96% |
Cash from investing | — | — |
Cash from financing | -46.91K | -102.36% |
Net change in cash | -1.05M | -8,516.83% |
Free cash flow | -3.63M | -139.97% |
About
Founded
2021
Headquarters
Website
Employees
1
